Reports + Research BioTime Changes Name and Moves to Carlsbad BioTime changed its name to Lineage Cell Therapeutics (NYSE: LCTX) and is relocating its corporate headquarters to Carlsbad in mid-August. Lineage Cell Therapeutics develops cell therapies f… […]
About this time last year, DNA sequencing giant Illumina upped its financial projections, estimating its sales would grow 20 percent year-over-year. It exceeded that goal, with revenue rising 21 percent to $3.33 billion by the end of 2018. It’s a diffe… […]
U.S. News & World Report. The annual “Best Hospitals” rankings are designed to assist patients and their doctors in making informed decisions about where to receive care for challenging health conditions. ]]>
LA JOLLA—Neurodevelopmental disorders arising from rare genetic mutations can cause atypical cognitive function, intellectual disability, and developmental delays, yet it is unclear why and how this happens. Scientists suspected a mutation in a complex… […]
SAN DIEGO–(BUSINESS WIRE)–$ILMN #ILMN–Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2019. Second quarter 2019 results: Revenue of $838 million, a 1% increase compared to $830 million in the… […]
As predicted by Bloomberg, cancer diagnostics company Exact Sciences is buying peer Genomic Health in a $2.8 billion cash-and-stock deal.
Exact Sciences’ flagship colorectal cancer test Cologuard will complement Genomic Health’s Oncotype DX, a test de… […]